P1–351: A novel BACE inhibitor (PF‐05297909): A two‐part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta‐amyloid in a first‐in‐human study. (1st July 2013) - Bell, Joanne; O'Neill, Brian; Brodney, Michael; Hajos‐Korcsok, Eva; Lu, Yasong; Riddell, David; Ito, Kaori; Ueckert, Sebastian; Nicholas, Timothy